Therapeutic Asset Ratings
1,482 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Busulphan
Central Nervous System Lymphoma
Sichuan University
P2/3
BB
(65)
Busulphan
Osteopetrosis
Masonic Cancer Center, University of Minnesota
P2/3
BB
(65)
Busulphan
Severe Combined Immunodeficiency
National Institute of Allergy and Infectious Diseases (NIAID)
P2/3
BB
(65)
Campath
Sickle Cell Disease
Columbia University
P2/3
BB
(65)
Capecitabine
Peritoneal Carcinomatosis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
P2/3
BB
(65)
Cediranib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P2/3
BB
(65)
Chiglitazar
Polycystic Ovary Syndrome
Shengjing Hospital
P2/3
BB
(65)
CIS-DIAMMINEDICHLOROPLATINUM II
Chemotherapy-Induced Toxicity
Zhiyong Yu
P2/3
BB
(65)
CIS-DIAMMINEDICHLOROPLATINUM II
Pancreatic Adenocarcinoma
Jonsson Comprehensive Cancer Center
P2/3
BB
(65)
Cyclophosphamide
Colorectal Cancer
University of Pennsylvania
P2/3
BB
(65)
Cyclophosphamide
Acquired Idiopathic Inflammatory Myopathy
Tongji Hospital
P2/3
BB
(65)
Cyclophosphamide
Severe Combined Immunodeficiency
St. Jude Children's Research Hospital
P2/3
BB
(65)
Eloxatin
Lung Cancer
Tango Therapeutics, Inc.
P2/3
BB
(65)
Empagliflozin
Ascites Hepatic
Alexandria University
P2/3
BB
(65)
Epirubicin
Uveal Melanoma
IDEAYA Biosciences
P2/3
BB
(65)
ETOPOSIDE
Large B-Cell Lymphoma
University of California, Davis
P2/3
BB
(65)
Famotidine
Sickle Cell Disease
Bristol-Myers Squibb
P2/3
BB
(65)
Fludarabine
Precursor B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P2/3
BB
(65)
gsk1120212
Cancer
Cancer Research UK
P2/3
BB
(65)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)
P2/3
BB
(65)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Lung Cancer
University of Chicago
P2/3
BB
(65)
Inno-206
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
University of Washington
P2/3
BB
(65)
Inno-206
T-Cell/Histiocyte Rich Large B Cell Lymphoma
Ruijin Hospital
P2/3
BB
(65)
Montelukast
Sickle Cell Disease
Great Ormond Street Hospital for Children NHS Foundation Trust
P2/3
BB
(65)
NORMAL HUMAN SERUM ALBUMIN
Cirrhotic Ascites
Protgen Ltd
P2/3
BB
(65)
Showing 176 to 200 of 1,482 assets
Previous
Page 8 of 60
Next